Previous Article | Next Article 
Journal of Clinical Microbiology, June 1999, p. 2099-2101, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Enhanced Amplified Mycobacterium Tuberculosis
Direct Test for Detection of Mycobacterium tuberculosis
Complex in Positive BACTEC 12B Broth Cultures of Respiratory
Specimens
John S.
Bergmann and
Gail L.
Woods*
Department of Pathology, University of Texas
Medical Branch, Galveston, Texas 77555-0740
Received 25 January 1999/Returned for modification 5 March
1999/Accepted 22 March 1999
 |
ABSTRACT |
The reliability of the Gen-Probe enhanced Amplified Mycobacterium
Tuberculosis Direct Test (MTD) for identification of
Mycobacterium tuberculosis complex (MTBC) in BACTEC 12B
broth cultures of respiratory specimens was evaluated by testing
aliquots from 268 bottles with a growth index of
50. MTD results were
compared to those obtained by usual laboratory protocol, whereby MTBC
was identified by DNA probe (Gen-Probe, Inc.) testing sediment from
broth samples or colonies on a solid medium. For the first 134 cultures, from which 68 mycobacterial isolates (including 27 MTBC
isolates) were recovered, both fresh and frozen aliquots were tested.
MTD results for the frozen aliquots agreed with the identification by
usual protocol in all cases, whereas there was one false-negative MTD
result with fresh aliquots. For the remaining 134 cultures, only frozen aliquots were tested. Of the total 268 broth cultures (from 210 patients) evaluated, 137 (51.1%) grew mycobacteria, including 60 MTBC
isolates. All 60 isolates were MTD positive, as was one additional
culture that grew Mycobacterium gordonae. The latter culture was from a patient who was diagnosed with tuberculosis a few
months earlier and was on therapy; therefore, the MTD result was
considered a true positive. Sensitivity, specificity, and positive and
negative predictive values of MTD were 100%. The mean times from
specimen receipt to identification of MTBC were 15 (±1) days (range, 4 to 27 days) for BACTEC plus MTD and 19 (±1) days (range, 6 to 36 days)
for the usual protocol (P < 0.001). These data
indicate that the MTD is a rapid, reliable method for identification of
MTBC in fresh or frozen aliquots of broth from positive BACTEC 12B
cultures of respiratory specimens.
 |
TEXT |
To help reverse the recent
resurgence of tuberculosis in the United States, use of the most
sensitive and rapid diagnostic laboratory tests available that provide
reliable results is recommended (1, 8). Currently, these
include a liquid and a solid medium for mycobacterial isolation and
nucleic acid probes, a chromatographic method, or the BACTEC TB NAP
(p-nitro-acetyl-amino-
-hydroxypropiophenone) test (Becton
Dickinson, Sparks, Md.) for identification of Mycobacterium tuberculosis complex (MTBC). In addition, two commercially
available nucleic acid amplification tests for direct detection of MTBC are the enhanced Amplified Mycobacterium Tuberculosis Direct Test (MTD;
Gen-Probe, Inc., San Diego, Calif.) and the AMPLICOR
Mycobacterium tuberculosis Test (Roche Diagnostic Systems,
Inc., Somerville, N.J.), but their use has been limited by the Food and
Drug Administration to testing respiratory specimens that are smear
positive for acid-fast bacilli (AFB) and which have been collected from
untreated patients. The target turnaround time suggested by the Centers
for Disease Control and Prevention for detection and identification of
MTBC is 21 days or less from receipt of a specimen in the laboratory (8).
Currently the 21-day target for detection and identification of MTBC
can only be achieved by use of a nucleic acid amplification test
directly from AFB smear-positive respiratory samples or by performing
one of the rapid identification tests on growth-positive broth
cultures. The latter method, however, occasionally yields false-negative results; i.e., the test is negative for MTBC, which then
is later identified by testing colonies on a solid medium (5). When this occurs, the identification of MTBC may be
delayed beyond 21 days. An alternative way in which the 21-day target for identification can be met is by performing nucleic acid
amplification on aliquots of broth from cultures in which mycobacterial
growth has been detected. The AMPLICOR assay has been shown to be a
reliable method for identification of MTBC in BACTEC 12B (Becton
Dickinson, Sparks, Md.) and ESP II (Trek Diagnostics [formerly AccuMed
International], Westlake, Ohio) broth samples (2, 3, 6, 7),
but to our knowledge the performance of the MTD has not been evaluated for this purpose. The intent of this study was to examine the reliability of the enhanced MTD, introduced in 1998, for detection of
MTBC in positive BACTEC 12B broth cultures.
Culture and identification.
Respiratory specimens submitted
for mycobacterial culture were decontaminated with 1% sodium hydroxide
(final concentration)-N-acetylcysteine and concentrated by
centrifugation at 3,000 × g for 20 min, according to
standard procedures (4). Approximately 0.2 ml of the
sediment was used to prepare a smear for staining with auramine O. To
the remaining sediment, phosphate buffer was added to give a final volume of 2.0 ml. For culture, 0.5 ml of the suspension was inoculated into a BACTEC 12B bottle, and 0.2 ml was inoculated onto each side of a
Middlebrook 7H11 biplate (Becton Dickinson).
BACTEC 12B bottles were incubated at 37°C in 8% CO2 and
monitored for growth for 5 weeks by the BACTEC 460 TB instrument
according to the manufacturer's instructions, as described in detail
elsewhere (4). When the growth index (GI) of a 12B bottle
reached
50, two 500-µl aliquots were removed for analysis by MTD.
Plates were incubated at 37°C in 8% CO2 and examined
weekly for growth for 6 weeks. Isolates of mycobacteria were identified
by DNA probes (AccuProbe; Gen-Probe, Inc., for MTBC,
Mycobacterium avium complex, Mycobacterium
kansasii, and Mycobacterium gordonae) or by
conventional biochemical tests (for rapidly growing mycobacteria)
performed according to standard protocol (4). Isolates not
identified by these procedures were referred to the Texas Department of
Health for identification by high-performance liquid chromatography
and/or conventional biochemical tests (4).
Enhanced MTD.
For each of the first 134 specimens, one aliquot
was refrigerated and tested by MTD within 72 h and one aliquot was
stored for up to 2 months at
70°C for batch testing. Thereafter,
both aliquots were stored at
70°C for batch analysis to optimize
labor efficiency for the purpose of this evaluation. MTD was performed and interpreted according to the manufacturer's protocol for processed respiratory specimens. Frozen aliquots were first thawed and vigorously agitated with a vortex mixer. Briefly, 50 µl of Specimen Dilution Buffer was added to each Lysing Tube, after which 450 µl of broth specimen, positive cell control, or negative cell control was added to
the correspondingly labeled tube. Tubes were vigorously agitated on a
vortex mixer for 3 s and then sonicated for 15 min at ambient
temperature in a water bath sonicator (Lab-Line Instruments, Melrose
Park, Ill.). To labeled amplification tubes, 50 µl of Mycobacterium
Tuberculosis Amplification Reagent and then 200 µl of Mycobacterium
Oil Reagent were added. Using an extended-length hydrophobically
plugged pipette tip, 25 µl of both the sample and control lysates
were transferred to the appropriate tube (the remaining lysate was
stored at
70°C for further testing, if necessary). Tubes were
incubated at 95°C for 15 min in a dry heat block and then transferred
to a 42°C water bath for 5 min. To each tube 25 µl of Mycobacterium
Enzyme Reagent was added; tubes were capped, gently shaken, and
incubated in a 42°C water bath for 30 min. Tubes were carefully
uncapped, and 100 µl of Hybridization Reagent was added. Tubes were
covered with new caps, vigorously agitated on a multitube vortex mixer
(VWR Scientific Products, West Chester, Pa.) for at least 30 s and
incubated in a 60°C water bath for 15 min. After hybridization, 300 µl of Selection Reagent was added. Tubes were covered with new caps,
vigorously agitated on a multitube vortex mixer for at least 30 s,
incubated in a 60°C water bath for 15 min, allowed to cool at ambient
temperature for 5 min, and read (in relative light units [RLU]) in a
luminometer (Leader 50; Gen-Probe, Inc.). Interpretation of results was
as follows: <30,000 RLU, negative;
500,000 RLU, positive; 30,000 to
500,000 RLU, equivocal. For samples yielding an equivocal result, a
second aliquot was tested; if the second result was
30,000 RLU, the sample was considered positive, whereas if it was <30,000 RLU, it was
considered negative. Results of the enhanced MTD were considered acceptable when the negative cell control was <20,000 RLU and the
positive cell control was
500,000 RLU. If the MTD result was
discordant from the result obtained by the usual laboratory protocol,
the MTD was repeated with the second aliquot and the patient's medical
record was reviewed.
Statistical analysis.
The Student's t test was
used to compare times to identification of MTBC in 12B broth cultures
by MTD (i.e., time from bottle inoculation until the culture reached a
GI of
50 and the aliquots of broth were removed for MTD analysis) and
by the usual laboratory protocol. For the usual laboratory protocol,
the interval was time from inoculation of a 12B bottle until the GI
reached 999, if the probe result for the broth sediment was positive,
and time from inoculation until colonies on the original solid medium
or on the solid medium to which broth from a positive 12B bottle was
subcultured were identified, if the probe result from the broth
sediment was negative.
Aliquots from a total of 268 12B broth cultures (210 patients) were
collected over 10 months for analysis by MTD. Results are summarized in
Tables 1 and
2. From the 134 cultures for which both
fresh (
72 h) and frozen aliquots were tested, mycobacteria ultimately
were isolated from 68 (50.7%) cultures as follows: 27 MTBC isolates,
25 M. avium complex isolates, 3 M. gordonae isolates, 5 Mycobacterium fortuitum-chelonae complex
isolates, 4 Mycobacterium nonchromogenicum isolates, 3 M. kansasii isolates, and 1 Mycobacterium
mucogenicum isolates. MTD results for the fresh aliquots were
positive for 26 of the 27 isolates that were culture positive for MTBC
and negative for the 107 isolates from which MTBC was not recovered
(sensitivity, 96.3%; specificity, 100%; positive predictive value
[PPV], 100%; negative predictive value [NPV], 99.1%). For the
frozen aliquots, the correlation between MTD and culture results was
100%. Based on these data, only frozen aliquots were tested thereafter
to optimize labor efficiency.
For the 268 frozen aliquots tested, 137 (51.1%) of the corresponding
cultures grew mycobacterial isolates as follows: 60 MTBC (34 patients),
38 M. avium complex, 15 M. fortuitum-chelonae
complex, 9 M. gordonae, 5 M. kansasii, 4 M. nonchromogenicum, 1 each M. mucogenicum, M. smegmatis, M. szulgai, and M. simiae, and in
2 cases an unequivocal identification was not possible (M. vaccae versus M. neoaurum was reported by the Texas
Department of Health). MTD results were positive for 61 of the 268 aliquots, including all those for which the culture grew MTBC and for
one culture which grew M. gordonae. For the latter culture,
the second aliquot was tested, and it, too, was MTD positive. Review of
this patient's medical record showed that he had been diagnosed with
tuberculosis several weeks earlier and was receiving antituberculous
therapy. Therefore, the MTD result was considered a true positive. The sensitivity, specificity, PPV, and NPV of the MTD for identification of
MTBC were 100%.
The mean times (± standard errors of the means) from receipt of the
specimen in the laboratory to identification of MTBC were 15 ± 1 days (range, 4 to 27 days) for BACTEC 12B plus MTD and 19 ± 1 days (range, 6 to 36 days) for the usual laboratory protocol, as
described above (P <0.001).
The exact cause of the initial incorrect MTD test result is unknown.
However, we suspect that for the culture for which the MTD results for
the fresh and frozen aliquots were discordant, the error occurred
during collection and labeling of the aliquots. This emphasizes the
need for close attention to detail and for taking care to avoid
distractions not only while performing the MTD assay but also during
initial preparation of the specimens for testing.
In summary, our data indicate that the enhanced MTD is a reliable
method for rapid detection of MTBC in positive (GI
50) BACTEC 12B
broth cultures of respiratory specimens. The performance of the MTD was
comparable for fresh versus frozen samples. In addition to reliability,
use of the MTD allows identification of MTBC in positive 12B cultures,
tested as soon as the GI reaches 50 or greater, in a significantly
shorter period of time than is possible by nucleic acid probe.
 |
ACKNOWLEDGMENTS |
Enhanced MTD kits for this study were kindly provided by Gen-Probe,
Inc. We appreciate the expertise provided by the University of Texas
Medical Branch medical technologists who work in the mycobacteriology laboratory.
G.L.W. was supported in part by a Tuberculosis Academic Award (1 K07
HL0333) from the National Heart, Lung, and Blood Institute, Bethesda, Md.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, University of Texas Medical Branch, Galveston, TX
77555-0740. Phone: (409) 772-4851. Fax: (409) 772-5683. E-mail:
gwoods{at}utmb.edu.
 |
REFERENCES |
| 1.
|
Anhalt, J. P.,
F. G. Witebsky, and G. L. Woods.
1993.
College of American Pathologists position statement regarding rapid detection of Mycobacterium tuberculosis.
Arch. Pathol. Lab. Med.
117:873[Medline].
|
| 2.
|
Forbes, B. A., and D. J. Pettit.
1995.
Ability of the Roche AMPLICORTM polymerase chain reaction (PCR) assay to identify Mycobacterium tuberculosis (MTB) in BACTEC 12B broth cultures, abstr. C-143, p. 25.
In
Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C.
|
| 3.
|
Hernandez, A.,
J. S. Bergmann, and G. L. Woods.
1997.
Amplicor MTB PCR test for identification of Mycobacterium tuberculosis in positive Difco ESP II broth cultures.
Diagn. Microbiol. Infect. Dis.
27:17-20[Medline].
|
| 4.
|
Nolte, F. S., and B. Metchock.
1995.
Mycobacterium, p. 400-437.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
|
| 5.
|
Reisner, B. S.,
A. M. Gatson, and G. L. Woods.
1994.
Use of Gen-Probe Accuprobes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii, and Mycobacterium gordonae directly from BACTEC broth cultures.
J. Clin. Microbiol.
32:2995-2998[Abstract/Free Full Text].
|
| 6.
|
Sierra, M. F.,
L. M. Clarke,
K. Abu-Lawi,
S. Eng,
A. Keen,
K. K. Young, and P. L. Hewitt.
1995.
Detection of M. tuberculosis, M. avium, and M. intracellulare from BACTEC 12B culture vials by PCR, abstr. U-87, p. 132.
In
Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C.
|
| 7.
|
Smith, M. B.,
J. S. Bergmann, and G. L. Woods.
1996.
Detection of Mycobacterium tuberculosis in BACTEC 12B broth cultures by the Roche Amplicor PCR assay.
J. Clin. Microbiol.
35:900-902[Abstract].
|
| 8.
|
Tenover, F. C.,
J. T. Crawford,
R. E. Huebner,
L. J. Geiter,
C. R. Horsburgh, Jr., and R. C. Good.
1993.
The resurgence of tuberculosis: is your laboratory ready?
J. Clin. Microbiol.
31:767-770[Free Full Text].
|
Journal of Clinical Microbiology, June 1999, p. 2099-2101, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, S. X., Sng, L. H., Tay, L.
(2004). Preliminary study on rapid identification of Mycobacterium tuberculosis complex isolates by the BD ProbeTec ET system. J Med Microbiol
53: 57-59
[Abstract]
[Full Text]
-
Zheng, X., Pang, M., Engler, H. D., Tanaka, S., Reppun, T.
(2001). Rapid Detection of Mycobacterium tuberculosis in Contaminated BACTEC 12B Broth Cultures by Testing with Amplified Mycobacterium Tuberculosis Direct Test. J. Clin. Microbiol.
39: 3718-3720
[Abstract]
[Full Text]
-
Desmond, E. P., Loretz, K.
(2001). Use of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for Early Detection of Mycobacterium tuberculosis in BACTEC 12B Medium. J. Clin. Microbiol.
39: 1993-1995
[Abstract]
[Full Text]